vimarsana.com

Page 252 - மருத்துவ அவசர ஊர்தி புதியது தெற்கு வேல்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agreement to advance MRD Test for Myeloma Investigations     Labmate Online

Jan 15 2021 Read 639 Times A license agreement with two Netherlands Institutes enabling development of a novel clinical laboratory test for minimal residual disease (MRD) status directly on serum samples of multiple myeloma patients has been announced by French company Sebia. The partnership with Erasmus University Medical Center in Rotterdam and the Radboud University Medical Center in Nijmegen, aims to offer a more accessible and sensitive MRD test based on serum-protein electrophoresis (SPE), immunofixation and free light chains. These techniques are recommended by the International Myeloma Working Group (IMWG). The specific terms of the agreement have not been disclosed. “Very high sensitivity MRD assessment in blood will revolutionise patients’ myeloma management and speed up therapeutic innovations. This unique personalised targeted mass spectrometry technology brings unprecedented clinical value in fighting myeloma,” said Pierre Sonigo, chief scientific officer at Se

New Jersey man admits role in pharmacy kickback scheme

Brillouin microscopy and Raman spectroscopy

Expert Insight: Brillouin microscopy and Raman spectroscopy: Emerging techniques for improved biomedical and clinical research Watch this on-demand webinar to discover how Brillouin microscopy and Raman spectroscopy can revolutionize your biophysical and biochemical analyses 14 Jan 2021 Dr. Francesca Palombo and Prof. Nick Stone, University of Exeter  In this exclusive double feature webinar, Dr. Francesca Palombo and Prof. Nick Stone, from the University of Exeter, reveal the power of Brillouin microscopy and Raman spectroscopy techniques for use in life sciences, biomedical, and clinical diagnostic applications. In the first part of this dual event, Dr. Palombo reviews the recent advances in Brillouin light scattering (BLS) microscopy and outlines the challenges and opportunities posed by the biomedical application of this emerging technique. In part two, Prof. Stone provides a clinical perspective on the utility of novel Raman approaches to pathology, point of care and open

Tennessee OKs Medicaid block grant; fate unclear under Biden

Tennessee OKs Medicaid block grant; fate unclear under Biden
lmtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lmtonline.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.